These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2935251)

  • 21. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS; Kanter PM
    Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genotoxic and mutagenic activity of antineoplastic anthracyclines and their aglycones: study in two test-systems].
    Vasil'eva SV; Makhova EV; Efremenkova OV; Bartoshevich IuE
    Genetika; 1996 Feb; 32(2):233-9. PubMed ID: 8713623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 25. Anthracyclines--modern tumour-inhibiting agents.
    Strauss DG
    Folia Microbiol (Praha); 1978; 23(2):152-61. PubMed ID: 348587
    [No Abstract]   [Full Text] [Related]  

  • 26. New anthracycline analogs in advanced breast cancer.
    Bonfante V; Ferrari L; Brambilla C; Rossi A; Villani F; Crippa F; Valagussa P; Bonadonna G
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1379-85. PubMed ID: 3470179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of anthracyclines with covalently closed circular DNA.
    Mong S; DuVernay VH; Strong JE; Crooke ST
    Mol Pharmacol; 1980 Jan; 17(1):100-4. PubMed ID: 6155600
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacokinetics of new anthracyclines].
    Robert J
    Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
    [No Abstract]   [Full Text] [Related]  

  • 35. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
    Long HJ; Schaid DJ; Schutt AJ; Ingle JN; Loprinzi CL; Edmonson JH
    Am J Clin Oncol; 1988 Oct; 11(5):524-7. PubMed ID: 2972192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of mitoxantrone in acute leukemia.
    Masaoka T; Shibata H; Oguma S; Nagai K; Kitani T; Horiuchi A; Yasunaga K; Yonezawa T; Kawagoe H
    Invest New Drugs; 1985; 3(2):197-201. PubMed ID: 3860489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
    Cini-Neri G; Neri B
    Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.